Article

marketwatch.com on 2019-08-29 15:21

AbbVie is shutting down its troubled Rova-T R&D program

Shares of AbbVie Inc. rose 1.5% in premarket trade Thursday after the company announced it had shut down its troubled Rova-T research and development...

Related news